Successful recovery from multiple organ failure associated with bicalutamide and leuprorelin acetate for prostate cancer
I report a case of multiple organ failure (acute kidney injury, interstitial pneumonitis and liver dysfunction) associated with combined androgen blockade(CAB) with bicalutamide and leuprorelin acetate for prostate cancer that was successfully managed by prompt hemodialysis and withdrawal of medicat...
Main Author: | Seiichi Saito |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Urology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442019304942 |
Similar Items
-
Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
by: Rajni Sethi, et al.
Published: (2009-06-01) -
ROLE OF LEUPRORELINE ACETATE DEPOT (LUCRIN DEPOT®) FORMULATIONS IN THE TREATMENT OF PROSTATE CANCER
by: M. I. Volkova
Published: (2014-07-01) -
ROLE OF LEUPRORELINE ACETATE DEPOT (LUCRIN DEPOT®) FORMULATIONS IN THE TREATMENT OF PROSTATE CANCER
by: M. I. Volkova
Published: (2014-07-01) -
LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?
by: V. B. Matveev, et al.
Published: (2014-08-01) -
LEUPRORELIN ACETATE DEPOT (ELIGARD) IN THE TREATMENT OF PROSTATE CANCER: WHAT DO PATIENTS WIN?
by: V. B. Matveev, et al.
Published: (2014-08-01)